JQ-1 ameliorates schistosomiasis liver granuloma in mice by suppressing male and female reproductive systems and egg development of Schistosoma japonicum.

Schistosomiasis is a serious and widespread parasitic disease caused by infection with Schistosoma. Because the parasite's eggs are primarily responsible for schistosomiasis dissemination and pathogenesis, inhibiting egg production is a potential approach to control the spread and severity of the disease. The bromodomain and extra-terminal (BET) proteins represent promising targets for the development of epigenetic drugs against Schistosoma. JQ-1 is a selective inhibitor of the BET protein family. In the present study, JQ-1 was applied to S. japonicum in vitro. By using laser confocal scanning microscopy and EdU incorporation assays, we showed that application of JQ-1 to worms in vitro affected egg laying and the development of both the male and female reproductive systems. JQ-1 also inhibited the expression of the reproductive-related genes SjPlk1 and SjNanos1 in S. japonicum. Mice infected with S. japonicum were treated with JQ-1 during egg granuloma formation. JQ-1 treatment significantly reduced the size of the liver granulomas and levels of serum alanine aminotransferase and aspartate aminotransferase in mice and suppressed both egg laying and the development of male and female S. japonicum reproductive systems in vivo. Moreover, the mRNA expression levels of some proinflammatory cytokines were decreased in the parasites. Our findings suggest that JQ-1 treatment attenuates S. japonicum egg-induced hepatic granuloma due at least in part to suppressing the development of the reproductive system and egg production of S. japonicum. These findings further suggest that JQ-1 or other BET inhibitors warrant additional study as a new approach for the treatment or prevention of schistosomiasis.

Introduction

Schistosomiasis is an acute and chronic parasitic disease caused by infection with Schistosoma, a parasite that is endemic in 78 countries and is responsible for approximately 280,000 deaths each year [1]. In China, zoonotic schistosomiasis caused by S. japonicum is major public health threat affecting more than a million people and hundreds of thousands of livestock [2].

Praziquantel is a widely used, high-efficiency, broad-spectrum, oral antiparasitic drug for the treatment of various forms of schistosomiasis, but praziquantel kills only adult worms and is minimally effective against immature schistosomes and eggs [2-3] In addition, the repeated and large-scale use of praziquantel in epidemic areas has led to drug resistance and a reduced cure rate [4-5]. Thus, there is an urgent need to identify new targets for the development of novel parasitic therapeutics. Owing to the key role of fertilized eggs in maintaining the life cycle and inducing pathogenesis [2-3], blocking egg production is a potential alternative approach to control the occurrence, development, and spread of schistosomiasis.

The bromodomain and extra-terminal (BET) family of proteins specifically recognizes acetylated lysine residue sites and participates in the regulation of epigenetic protein expression, which plays a key role in regulating various biological processes [6]. JQ-1 is a selective inhibitor of BET family proteins and has been shown to have promising anti-tumor and anti-inflammatory effects [7]. In a pilot study, we used JQ-1 to treat hepatic granuloma caused by infection with S. japonicum. Mice infected with S. japonicum cercariae were injected intraperitoneally with JQ-1 (50 mg/kg) during egg granuloma formation. Unexpectedly, JQ-1 significantly reduced the sizes of the liver granuloma and egg burden; however, JQ-1 treatment had no effect on worm load. We hypothesized that JQ-1 would be effective in inhibiting egg production in S. japonicum and sought to explore the mechanisms underlying this effect.

Thus, the aim of the present study was to confirm that JQ-1 reduces egg production of S. japonicum and to investigate the potential mechanisms undergirding this effect. To that end, we applied JQ-1 to schistosomes in vitro and assessed the effects on their reproductive development and egg production. We also treated C57BL/6 mice infected with S. japonicum with JQ-1 to assess the effects of the drug on hepatic granuloma and liver function. Our findings indicated that JQ-1 inhibited the reproductive development of male and female S. japonicum and reduced egg production of the parasite while ameliorating hepatic granuloma and improving liver function in infected mice. These findings lay a foundation for further study to develop JQ-1 or other BET inhibitors as a new approach for the treatment and prevention of schistosomiasis.

Materials and methods

Ethics statement

All experiments carried out on animals were conducted in accordance with and were approved by the Animal Ethics Committee of Anhui Medical University (approval No. LLSC20170247) and conformed to the guidelines outlined in the Guide for the Care and Use of Laboratory Animals. All infection was performed under anesthesia, and all efforts were made to minimize suffering.

Animals and parasites

Female Kunming mice (6–8 weeks old) and female C57BL/6 mice (6–8 weeks old) were provided by the Experimental Animal Center of Anhui Province in Hefei, China. The mice were housed under specific pathogen-free conditions at Anhui Medical University. Oncomelania hupensis snails infected with S. japonicum (a Chinese mainland strain) were purchased from the Jiangxi Provincial Institute of Parasitic Diseases in China.

Treatment of schistosomes with JQ-1 in vitro

Cercariae were shed in a beaker after exposing 30 O. hupensis infected with S. japonicum to sunlight for 4 h (25–28°C). For mixed infections, cercariae released from several infected O. hupensis were used. Kunming mice were infected percutaneously with 80–90 cercariae and were humanely killed on the 28th day after infection. All paired parasites were harvested by perfusion and washed three times with RPMI-1640 medium. The worms were then cultured in vitro with RPMI-1640 (Gibco, Grand Island, NY, USA) at 37°C and 5% CO2. The RPMI-1640 medium was supplemented with 10,000 U/mL penicillin, 10 mg/mL streptomycin, 250 μg/mL amphotericin B (Sangon Biotech, Shanghai, China), 15% fetal calf serum (Gibco), and glutamine (Gibco). For each experiment, 15 pairs of S. japonicum were maintained in a 6-well plate (i.e., 15 pairs/well). JQ-1 (Cat. No. HY-13030, MedChem Express; USA), was dissolved in dimethyl sulfoxide (DMSO). In each experimental group, 15 paired parasites were incubated in 3 mL of medium and treated with different concentrations of JQ-1 (0 μM, 5 μM, 10 μM, and 15 μM). All parasites were cultured at 37°C for 10 d, and culture media was changed every 24 h. During this time, the viability and morphology of parasites, worm pairings, and the number of eggs were observed and recorded.

Confocal laser scanning microscopy (CLSM)

For morphological analysis, collected worms were fixed in a solution of alcohol (95%), formalin (3%), and glacial acetic acid (2%) for at least 24 h. Worms were stained in hydrochloric acid–carmine dye (Ourchem, Shanghai, China) for 17 h and then destained in acidic 70% ethanol until the worms turned light pink. The worms were dehydrated in a graded ethanol series (70%, 90%, and 100%), cleared in 50% xylene diluted in ethanol and in 100% xylene for 1 min each, mounted onto slides with neutral gum, sealed with cover glass, and laid flat to dry. The morphology of their reproductive organs was observed with a CLSM (ZEISS LSM 880, Germany) using an emission wavelength of 488 nm. Images were captured and stored at 1024 × 1024 pixels.

5-ethynyl-2′-deoxyuridine (EdU)-incorporation assay

For EdU labelling and detection of proliferating cells, paired worms treated with JQ-1 and control worms were incubated with 10 mM of EdU in medium for 24 h. BeyoClick EdU-594 Cell Proliferation Kits (Beyotime, Shanghai, China) were used to detect EdU incorporation. Couples were separated, fixed, and stained as described above, with minor alterations. The couples were rinsed twice in PBS and stained with Hoechst 33342 (diluted 1:1000 in PBS) in the dark for 10 min at room temperature. The worms were examined by CLSM using a ZEISS LSM 880 confocal microscope at a wavelength of 405 nm (for Hoechst) and 543 nm (for Azide 594).

Treatment of schistosomes with JQ-1 in vivo

Four weeks after mice were infected with S. japonicum, mice in the experimental group were injected intraperitoneally with JQ-1 (50 mg/kg body weight per day), and mice in the control group were injected intraperitoneally with vehicle, namely, (2-hydroxypropyl)-β-cyclodextrin (HP-β-CD; Cat. No. 778966, Sigma; USA) 10% (wt/vol), once daily for 15 d. Animals were humanely killed 24 h after the last administration. The parasites, serum, and liver from each mouse were collected for subsequent experimental analyses.

Quantitative PCR

Total RNA from adult S. japonicum worms or the liver of each mouse was isolated using TRIzol Reagent (Life Technologies, Carlsbad, CA, USA). The total RNA concentration and purity were detected using a NanoDrop 2000 system (Thermo Fisher Scientific, USA). Total RNA (500 ng) from the worms was reverse transcribed to cDNA by using a PrimeScript RT Reagent Kit (TaKaRa, Dalian, China) according to the manufacturer’s instructions. A reliable reference gene for transcriptome analysis of S. japonicum, PSMD4, was used as a control gene in the assays [8], and GAPDH was used as a control gene for transcriptome analysis of the liver. The experiment was carried out using the StepOnePlus Real-Time PCR System (Applied Biosystems, Foster City, CA, USA). The relative expression level of each gene was analyzed using SDS v.1.4 software (Applied Biosystems). The procedure for quantitative PCR analysis was conducted as described previously [9], and the primers were designed and synthesized by Sangon Biotech Co. Ltd. The PCR primer sequences are described in the S1 Table.

Serum liver enzyme quantification

For assessment of mouse liver function, a serum aminotransferase test kit (Nanjing Jiancheng Bioengineering Institute, Nanjing, China) was used to measure the levels of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST), according to the manufacturer’s instructions. The levels of serum ALT and AST are reported in units per liter.

Egg count in liver tissue

Approximately 0.1 g of liver tissue was collected from the same area of the liver in each mouse and weighed. Potassium hydroxide (10%; 1 mL) was added to the liver tissue for digestion at 37°C for 2 h. The number of eggs in each sample was then counted using a light microscope.

Histology and immunohistochemistry of liver sections

Fresh liver tissue (1.0 g) was fixed in 1% buffered formalin and embedded in paraffin. The deparaffinized tissue sections were affixed to slides, and sections (thickness, 4 μm) were stained with hematoxylin and eosin and examined for quantitative and qualitative changes. Computer-assisted morphometric software (Image-Pro Plus; Media Cybernetics) was used to determine the total areas of the tissue and granuloma on each slide so that the area of the granulomas could be reported as a percentage of the total area for each slide. For each specimen, at least three non-continuous slides were measured, and the mean values obtained from eight mice in each group were used for statistical analysis.

Statistical analysis

Statistical analysis was performed using GraphPad Prism software (version 6.0). All data were obtained from three independent experiments, each using triplicate samples and following the same protocol. The statistical significance of the difference between two data sets was analyzed using Student’s t-test, and one-way analysis of variance (ANOVA) was used for multiple comparisons, followed by Tukey’s post hoc tests when appropriate. Data are presented as means ± SEM and were considered statistically significant for P-values <0.05.

Results

Effects of JQ-1 treatment on pairing rate and egg production

The number of male-female paired worms was counted on the 10th day of culture to determine the effect of JQ-1 treatment on the pairing rate. We found that the number of paired worms in the cultures treated with JQ-1 was similar to that in the control group treated with vehicle (Fig 1A). No significant changes in schistosome activity or in the number of viable worms were detected between the JQ-1-treated group and the control group. However, the number of eggs collected in the medium and counted using light microscopy was decreased in the cultures treated with JQ-1 compared with controls (Fig 1C–1F). To further analyze the effects of JQ-1 on egg production in the paired females, we counted egg numbers and found that compared with the DMSO-treated group, the number of eggs (P < 0.001) in the JQ-1-treated group decreased in a concentration-dependent manner (Fig 1B).

Fig 1

Effect of JQ-1 on male-female pairing rate, egg production, and egg morphology in S. japonicum.

Effects of different concentrations (5 μM, 10 μM, and 15 μM) of JQ-1 application on male-female pairing stability (A), egg production (B), and egg morphology (C-F) in S. japonicum pairs cultured in vitro for 10 d. Data represent the mean ± SEM of three independent experiments. Scale bars: 200 μm. Asterisks show statistical differences (***P < 0.001) tested by one-way ANOVA with multiple comparisons (Tukey’s post-hoc test).

JQ-1 treatment decreases mitotic activity in somatic and germ cells

We investigated whether JQ-1 affects mitosis in S. japonicum by performing EdU-incorporation assays using JQ-1-treated worms to assess cell proliferation. Worm pairs treated with JQ-1 for 10 d exhibited a substantial decrease in the number of EdU-labeled cells in the gonads, parenchyma, and subtegument of both sexes. In the untreated control group, a substantial number of EdU-labeled cells were detected in the vitellarium and ovary of adult females as well as in the testis and parenchyma of adult males (Fig 2), which indicated high mitotic activity in these organs. Adult worms treated with JQ-1 for 10 d showed a slight decrease in the number of EdU-positive cells in the vitellarium of females and the testis and parenchyma of males; greater decreases were observed with increasing concentrations of JQ-1. At the highest concentration, JQ-1–treated worm organs and tissues had almost no EdU-labeled cells (Fig 2D and 2H).

Fig 2

Effect of JQ-1 on cell proliferation in male-female pairs of S. japonicum.

Red signals indicate active mitotic cells labeled by EdU; blue signals, Hoechst-positive cells. (A-D) Male S. japonicum and (E-H) female S. japonicum. EdU-incorporated cells are detected in the testes and parenchyma of untreated males (A) and in the vitellarium and ovary of untreated females (E). EdU-positive cells are detected after application of JQ-1 at 5 μM (B, F), 10 μM (C, G), and 15 μM (D, H). Abbreviations: ov, ovary; t, testes; SV, seminal vesicles. Scale bars: 200 μm.

Effects of JQ-1 treatment on reproductive organ development

Consistent with the observed decreased egg production, CLSM analyses of worm pairs treated with JQ-1 revealed morphologic abnormalities in the gonads of both sexes. After treatment for 10 d, no morphological anomalies were observed in the testes and vesicles of the males (Fig 3A and 3E) or the ovaries of the females (Fig 4A) in the control group. The testes of DMSO-treated male schistosomes were composed of several testicular lobes arranged bead-like, and each testicular lobe contained a large number of spermatocytes and spermatogonia at different stages (Fig 3A–3D), The size of the testicular lobes in the group treated with the high concentration of JQ-1 was much smaller than that in the DMSO-treated group, and the numbers of spermatogonia and spermatocytes in the male testes were significantly reduced and more loosely arranged (Fig 3D). The results of CLSM (Fig 3E–3H) showed that the number of spermatozoa in the seminal vesicles of schistosomes in the JQ-1-treated group was reduced, and the development of the spermatozoa was impaired. Compared with controls, the group treated with JQ-1 showed a markedly reduced diameter of the testicular lobes (Fig 3I), which was paralleled by a reduction in cell density within the testes as well as by empty seminal vesicles. In the group treated with JQ-1, the morphology of whole germ cells in both the testis and ovary were markedly changed. Those changes were more obvious with increasing concentrations of JQ-1. The ovaries of the DMSO-treated female schistosomes were composed of small immature oocytes in the anterior part and larger primary oocytes in the posterior part, the sizes of the primary oocytes and immature oocytes were reduced, and the cells of the JQ-1-treated groups were not as full as the cells of DMSO-treated groups (Fig 4A–4D). The length and width of the ovaries in females treated with JQ-1 were significantly smaller than those of untreated controls (Fig 4I–4K). Large pore-like structures were observed in the testes and ovaries of males and females, respectively (Figs 3 and 4). These morphological changes in both females and males were greatest after treatment with the highest concentration (15 μM) of JQ-1.

Fig 3

Morphological changes of spermatozoa in testes and seminal vesicles of S. japonicum treated with JQ-1 in vitro.

Worms were stained with carmine hydrochloride and analyzed using confocal laser scanning microscopy. (A, E) Control worms; worms treated with JQ-1 at 5 μM (B, F), 10 μM (C, G), and 15 μM (D, H). (A-D) Scale bars: 20 μm; (E-H) Scale bars: 10 μm. Abbreviations: t, testis; SV, sperm vesicle. (I) Comparison of the diameter of the testicular lobes after JQ-1 application at the indicated concentration for 10 d. Data represent the mean ± SEM (n ≥ 15 for each group). Asterisks show statistical differences (**P < 0.01; ***P < 0.001) tested by one-way ANOVA with multiple comparisons.

Fig 4

Morphological changes of ovaries and yolk glands in female S. japonicum treated with JQ-1.

Worms were stained with carmine hydrochloride and analyzed using confocal laser scanning microscopy. (A, E) Control worms; worms treated with JQ-1 at 5 μM (B, F), 10 μM (C, G), and 15 μM (D, H). Abbreviations: ov, ovary; v, vitellarium; (A-H) Scale bars: 20 μm. Comparison of the length, width, and area of the ovary after JQ-1 application at the indicated concentration (I-K) for 10 d. Data represent the mean ± SEM (n ≥ 15 for each group). Asterisks show statistical differences (**P < 0.05, **P < 0.01, ***P < 0.001) tested by one-way ANOVA with multiple comparisons.

JQ-1 treatment decreases SjNanos1, SjPlk1 mRNA levels

To explore the mechanisms undergirding the observed effects of JQ-1 on S. japonicum, we used quantitative PCR to detect the levels of the S. japonicum protein coding genes polo-like kinase 1 (SjPlk1) and SjNanos1, two genes related to schistosome reproduction, after application of different concentrations of JQ-1 in vitro. Compared with the control group, the expression levels of SjNanos1 mRNA in the JQ-1-treated worms were down-regulated in both males (Fig 5A) and females (Fig 5B), and this effect was more marked with increasing concentrations of JQ-1. Similarly, the expression levels of SjPlk1 mRNA were also down-regulated in both males and females, and this effect was also more marked with increasing concentrations of JQ-1 (Fig 5C and 5D). However, JQ-1 treatment did not affect the expression of SjBrd2 mRNA (Fig 5E and 5F).

Fig 5

Results of quantitative PCR analyses of S. japonicum cultured with or without JQ-1 for 10 d.

Relative transcription level of Nanos1 in male (A) and female S. japonicum (B). Relative transcription level of Plk1 in male (C) and female (D) S. japonicum. Relative transcription level of Brd2 in male (E)€ and female (F) S. japonicum. Data represent the mean ± SEM of three independent experiments. Asterisks show statistical differences (*P < 0.05; **P < 0.01) tested by one-way ANOVA with multiple comparisons.

JQ-1 ameliorates liver granuloma caused by S. japonicum infection

In the fourth week after S. japonicum infection, mice in the experimental group were injected with JQ-1, and mice in the control group were injected with the vehicle HP-β-CD, once daily for 15 d. All mice were humanely killed after 15 d of treatment (Fig 6A). As shown in Fig 6B, livers obtained from mice in the HP-β-CD group had large agglomeration, and granuloma inflammation was severe. However, there was marked reduction of liver surface granulomatous nodules in the JQ-1-treated group. The livers obtained from mice in the JQ-1-treated group were lighter and more vivid in color, and the surface was relatively smooth, compared with the livers from mice in the control group. Hematoxylin and eosin staining of the liver showed that the percentage of the area of the liver that had granulomas in the JQ-1-treated group was significantly reduced compared with that in the HP-β-CD control group (Fig 6C) (P < 0.01). In addition, the weights of the liver and spleen obtained from mice treated with JQ-1 were significantly lower than those from control mice (Fig 6D and 6E). Moreover, the results of the AST and ALT assays showed that the activity of serum transaminase in the JQ-1–treated group was significantly lower than that in the control group (Fig 6F) (P < 0.05). To further explore the effect of JQ-1 treatment to ameliorate hepatic granuloma in mice infected with S. japonicum, we used quantitative PCR to detect the expression levels of a series of inflammatory factors. The mRNA expression levels of the genes in the HP-β-CD–treated control group were set at 1. As shown in Fig 6G, the mRNA expression levels of the inflammatory factors in the JQ-1-treated group relative to those in the control group were significantly decreased (P < 0.05). Notably, the expression level of interleukin 13, an inflammatory factor closely related to the formation of granuloma caused by S. japonicum, was significantly reduced.

Fig 6

Effect of JQ-1 treatment on liver granuloma in mice infected with S. japonicum.

(A) Protocol used to assess liver granuloma in mice. (B) Gross appearance of livers obtained from mice infected with S. japonicum and treated with JQ-1 or vehicle (HP-β-CD). Liver slices stained with hematoxylin and eosin. Scale bars: 500 μm. (C) Measurement of granuloma area as a percentage of total area as assessed by computer-aided morphometry. (D) Liver weights of S. japonicum infected mice treated with JQ-1 or HP-β-CD. (E) Spleen weights of S. japonicum infected mice treated with JQ-1 or HP-β-CD. (F) Effect of JQ-1 treatment on serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in mice infected with S. japonicum. (G) Effect of JQ-1 treatment on mRNA expression of inflammation-related genes in the liver of mice infected with S. japonicum. Data represent the mean ± SEM (n  =  9 for each group). Asterisks denote statistically significant differences (Student’s t-test, *P < 0.05; **P < 0.01) vs. the HP-β-CD–treated control group.

Effects of JQ-1 treatment on schistosome eggs in the liver and on adult worms in mice infected with S. japonicum

The above results suggested that JQ-1 alleviated liver injury caused by schistosome infection to some extent and reduced the formation of hepatic granuloma in mice. To observe whether JQ-1 affected S. japonicum eggs in the liver, we evaluated the quantity of eggs in the liver of mice in the JQ-1-treated group compared with that in the HP-β-CD-treated control group after schistosome infection. The liver tissue obtained following digestion with 10% potassium hydroxide was used to observe the morphology of the eggs and to count them. We found that the proportion of abnormally small or dead eggs was increased in the JQ-1-treated group (Fig 7A and 7B). The volume of eggs in the liver of JQ-1-treated infected mice was approximately 40% lower than that of control mice injected with HP-β-CD (Fig 7B). By contrast, the numbers of adult worms and worm pairs in the livers of the JQ-1–treated group were not affected (Fig 7C and 7D). Although this effect in the treated group may have been due to the significant decrease in the number of eggs or to the increase in the number of small or dead eggs, it may also be related to the immune regulation of JQ-1 in mice. JQ-1 treatment decreased the expression of SjNanos1and SjPlk1 mRNA, but there was no statistically significant difference between the treated group and the control group (Fig 7E and 7F). We used an EdU-incorporation assay to assess the proliferation of germ cells in schistosomes of infected mice (Fig 7G). Although some differences between the control group and the treated group were observed, the differences were not as obvious as those observed in the in vitro experiments.

Fig 7

JQ-1 treatment alters germ cell proliferation of S. japonicum and egg production in the liver of mice infected with S. japonicum.

(A) Egg morphology and (B) production in the liver. (C) Numbers of adult worms and (D) worm pairs in the liver. (E-F) Results of quantitative PCR analyses of Red signals indicate active mitotic cells labeled by EdU; blue, Hoechst-positive cells. EdU-incorporated cells in control worms were detected in the testes and parenchyma of males and in the vitellarium and ovary of females. (A) Scale bars: 500 μm. (G) Abbreviations: ov, ovary; t, testes. Scale bars: 100 μm. Data represent the mean ± SEM (n  =  9 for each group). Asterisks denote statistically significant differences (Student’s t test, ** P < 0.01).

CLSM analyses of the JQ-1-treated group revealed morphologic abnormalities in the gonads of both sexes. In the control HP-β-CD-treated group, no morphological anomalies were observed in the testes of the males (Fig 8A) or the ovaries of the females (Fig 8C). By contrast, compared with the control group, the number of spermatozoa in the seminal vesicles of schistosomes in the JQ-1-treated group was reduced and the development of spermatozoa was impaired (Fig 8B and 8E). In addition, in JQ-1 treatment group, the overall morphology of the germ cells of schistosomes in both the testis and ovary were markedly changed. Moreover, large pore-like structures could be found in the testes and ovaries of male and female schistosomes, respectively, in the JQ-1-treated group (Fig 8D and 8F).

Fig 8

Morphological changes in the testis and ovary of S. japonicum treated with JQ-1 in vivo.

Worms were stained with carmine hydrochloride and analyzed using confocal laser scanning microscopy. (A-C) Testes, seminal vesicles, and ovary of worms in control mice. (D-F) Testes, seminal vesicles and ovary of worms in mice treated with JQ-1. Abbreviations: ov, ovary; t, testes; SV, seminal vesicles. Scale bars: 20 μm.

Discussion

The present study assessed the effects of JQ-1 application on S. japonicum in vitro and in vivo and investigated the potential mechanisms undergirding the observed effects. The results of our in vitro studies indicated that although JQ-1 application did not affect the number or pairing of adult schistosomes, the number of eggs decreased in a concentration-dependent manner. In addition, mitotic activity in the somatic and germ cells of the adult worms decreased. The numbers of spermatogonia and spermatocytes were significantly decreased and the testicular lobes were significantly smaller in male schistosomes treated with JQ-1 compared with schistosomes in the control group. Moreover, large pore-like structures were observed in the testes and ovaries of JQ-1-treated schistosomes. These results suggested that JQ-1 specifically inhibited the proliferation of germ cells. Our EdU incorporation assays confirmed that JQ-1 reduced the number of proliferating cells in both the ovaries and testes of schistosomes. Proliferation of those cells is essential for the initiation and continuous production of mature germ cells. Treatment with JQ-1 also decreased the expression levels of two genes related to schistosome reproduction, SjPlk1 and SjNanos1, in a concentration-dependent manner. Thus, this study is the first, to our knowledge, to show that JQ-1 is effective against reproductive development and egg production of adult S. japonicum in vitro. In schistosomiasis in humans, morbidity is mainly attributed to the eggs because of the granulomatous inflammatory reaction caused by the host immune response to egg antigens [2-3]. Thus, we assessed the ability of JQ-1 to treat hepatic granuloma in mice infected with S. japonicum in vivo. JQ-1 treatment significantly decreased the percentage of the area of the liver with granulomas, the activity of liver serum transaminase, and schistosome egg production in the liver of mice without affecting the survival of adult worms. The attenuated egg production was accompanied by decreased expression levels of proinflammatory cytokines, which may have contributed to the amelioration of hepatic granuloma. Taken together, our findings provide evidence supporting the development of JQ-1 as an anti-schistosomal agent.

The BET family proteins are characterized by the presence of two tandem bromodomains and an extra-terminal domain, which are found in BRD2, BRD3, BRD4, and BRDT in mammals [6]. The domain organization of mammalian BET proteins is conserved in orthologs, including in Drosophila FSH and Saccharomyces cerevisiae Bdf1 and Bdf2. Bromodomains that specifically bind acetylated lysine residues in histones serve as chromatin-targeting modules that decipher the histone acetylation code. BET proteins play a crucial role in regulating gene transcription through epigenetic interactions between bromodomains and acetylated histones during cell proliferation and differentiation [10-11]. Brd2 mRNA is express in distinct patterns during ovarian folliculogenesis, which is essential for embryonic development in the mouse [12-13]. Brdt acetylated histone H4-dependent chromatin remodeling in mammalian spermiogenesis is essential for male germ cell differentiation [14-15]. In addition, a BRDT-like function in Drosophila plays crucial roles in spermatid differentiation [16]. Epigenetic modifications, including DNA methylation, histone modifications, and non-coding RNAs, play important roles in the development and reproduction of schistosomes [17]. SmGCN5 and SmCBP1 are two histone acetyltransferases in Schistosoma mansion. The knockdown of SmGCN5 or SmCBP1 significantly inhibits Smp14 expression, which compromises the reproductive system of mature females, egg-laying, and egg morphology [18]. Sirtuins are a family of histone deacetylases, and sirtuin inhibitors can inhibit apoptosis and death in schistosome larvae, disruption of adult worm pairs, inhibition of egg laying, and damage to male and female worm reproductive systems [19-20].

As a first-in-class, potent, and selective inhibitor of the BET signaling pathway, JQ-1 has been widely used in biology studies. The results of some of those numerous studies indicate that JQ-1 interacts with the BRD pocket in a manner competitive with acetylated peptide binding, resulting in the displacement of BET proteins from acetylated chromatin in cells exposed to these inhibitors and disruption of their associated transcript initiation and elongation factors. JQ-1 has also been used as a pharmacological tool for elucidating the roles and functions of BET in mammals. However, little is known about the effect of JQ-1 on parasites.

Nanos has been described as a necessary factor in the differentiation and migration of primordial germ cells, which play an essential role in the proliferation of germ cells in schistosomes [21-22]. SmPlk1 regulates the cell cycle G2/M transition in Xenopus oocytes, which is important for cell-cycle progression in the gonadal cells of Schistosoma [23-24]. In the present study, we investigated whether JQ-1 also affected the transcript level of Nanos1 and Plk1. Indeed, treatment with JQ-1 significantly reduced the transcript levels of both these genes in male and female worms, which likely affected the proliferation of the gonadal cells in Schistosoma.

This study has limitations that should be considered when interpreting our results. On the basis of previous publications [25-26], we used only a single dose of JQ-1 (50 mg/kg) to treat mice infected with S. japonicum for 15 d. Thus, we were unable to make any comparisons of the effects after various treatment times or dosage on parasites in infected mice. Future studies are needed to find the optimum therapeutic dosage.

In conclusion, our data showed that JQ-1 treatment ameliorated S. japonicum egg–induced hepatic granuloma, which may be due in part to suppressing the development of both the male and female reproductive systems and female egg production in this parasite. Our findings provide theoretical and practical evidence supporting the development of JQ-1 as an anti-schistosomal agent.

Sequences of quantitative PCR primers in this study.

(DOCX)

Click here for additional data file.

27 Apr 2022

Dear Dr. Miao Liu,

Thank you very much for submitting your manuscript "JQ-1 ameliorates schistosomiasis liver granuloma in mice by suppressing male and female reproductive systems and egg development of Schistosoma japonicum" for consideration at PLOS Neglected Tropical Diseases. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. In light of the reviews (below this email), we would like to invite the resubmission of a significantly-revised version that takes into account the reviewers' comments.

We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent to reviewers for further evaluation.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Please prepare and submit your revised manuscript within 60 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. Please note that revised manuscripts received after the 60-day due date may require evaluation and peer review similar to newly submitted manuscripts.

Thank you again for your submission. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Alessandra Morassutti, PhD

Associate Editor

PLOS Neglected Tropical Diseases

Maria Elena Bottazzi

Deputy Editor

PLOS Neglected Tropical Diseases

***********************

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: (No Response)

Reviewer #2: (No Response)

--------------------

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: (No Response)

Reviewer #2: (No Response)

--------------------

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: (No Response)

Reviewer #2: (No Response)

--------------------

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: (No Response)

Reviewer #2: (No Response)

--------------------

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: The author studied the effect of JQ-1 on reproductive systems and egg development of Schistosoma japonicum to ameliorates liver granuloma in mice. The authors detected the male-female pairing rate, egg production, reproductive system and the expression of related genes of Schistosoma japonicum after JQ-1 treatment in vivo and in vitro. The data suggested JQ-1 treatment ameliorated S. japonicum egg–induced hepatic granuloma and suppressing the development of both the male and female reproductive systems and female egg production. This manuscript be of interest. However, there are some concerns about this paper.

Major concerns

1. JQ-1 is the inhibitor of BET. The mRNA and protein expression levels of BET protein family should be detected in this study. Authors may provide such data in different groups with or without JQ-1 treatment.

2. Please include some positive controls for JQ-1 treatment in in vivo and in vitro models.

3. No negative control group (normal control) in In vitro experiment

4. Effect of JQ-1 on cell apoptosis in male-female pairs of S. japonicum should be included.

5. Why did the author treat the S.japonicum infected mice with JQ-1 after four weeks’ infection? Please provide the reasons in the manuscripts.

6. It would be nice to detect the levels of SjNanos1, SjPlk1 mRNA in vivo.

7. JQ-1 has also been used as a pharmacological tool for elucidating the roles and functions of BET in mammals. How to evaluate the effect of JQ-1 on host mice? Do JQ-1 has the toxic effects on mice, especially hepatotoxicity? And how about the expression of inflammatory factors in mice treated with JQ-1 alone.

8. The method of egg count in liver tissue is not clear. Because eggs deposited in liver are not evenly in schistosomiasis mice, liver tissues should be taken in the fix sites in each mouse in control group and test group.

9. The Figures problems:1) Illustrations for Fig 3 and Fig 4 were misplaced; 2) Fig 4, the labeled texts on axes in graphs are blurred and indistinct. 3) Fig5: the present graphs are unreasonable; the text labeled on axes are not accurate. 4）Fig7: graphs should be combined. 5) the morphological photos in Fig2,3,4,8,9 should be marked with test groups in figures and provided more illustration details.

Minor errors:

10. The English of the manuscript needs to be carefully edited.

11. P1 line15-16: Schistosomiasis is a serious and widespread parasitic disease caused by infection with Schistosoma japonicum._

12. Revised：…….by infection with Schistosoma.

13. P2 line38-39: schistosomiasis is a serious disease caused by infection with the parasite Schistosomiasis japonicum.

14. Revised：schistosomiasis japonicum is a serious disease caused by infection with the parasite S. japonicum.

15. P3 line58: S. japonicum. — Use italics and check the whole text especially in reference part.

16. P4 line74: Schistosoma japonicum — revised: S. japonicum. and check the whole text.

Reviewer #2: In this study, the effects of JQ-1, a selective inhibitor of BET protein family, on adult worm development of Schistosoma japonicum, especially reproductive system development, were investigated. The results showed that JQ-1 could reduce the egg laying and the germ cell division in the adult worms in vitro and in vivo, which resulted in the decrease of egg granuloma formation and release of proinflammatory factors in liver of the infected mice. However, when considering the use of JQ-1 as an anti-schistosomiasis drug, the authors do not answer or ignore two important questions: 1.The fate of eggs treated with JQ-1, that is, whether they can still be excreted from the intestine. 2. Whether or not JQ-1 has the effects on host germ cells? Otherwise, it is not practical or reasonable to evaluate the pharmacological effect of JQ-1 on Schistosoma japonicum reproduction. Although the authors also observed that JQ-1 inhibited the expression of reproductive genes SjPlk1 and SjNanos1 in the worms, they did not discuss the relationship between these effects and the known influence of JQ-1 on the function of mammalian BET proteins.

--------------------

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

18 Jun 2022

Submitted filename: Response to reviews for plos ntd1(1)CLEAN.docx

Click here for additional data file.

13 Jul 2022

Dear Miao Liu,

We are pleased to inform you that your manuscript 'JQ-1 ameliorates schistosomiasis liver granuloma in mice by suppressing male and female reproductive systems and egg development of Schistosoma japonicum' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Alessandra Morassutti, PhD

Academic Editor

PLOS Neglected Tropical Diseases

Maria Elena Bottazzi

Section Editor

PLOS Neglected Tropical Diseases

***********************************************************

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: (No Response)

Reviewer #2: (No Response)

**********

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: (No Response)

Reviewer #2: (No Response)

**********

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: (No Response)

Reviewer #2: (No Response)

**********

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: (No Response)

Reviewer #2: (No Response)

**********

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: The author answered all questions I raised. The current manuscript has allayed my concerns.

Reviewer #2: (No Response)

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

26 Jul 2022

Dear Dr Liu,

We are delighted to inform you that your manuscript, "JQ-1 ameliorates schistosomiasis liver granuloma in mice by suppressing male and female reproductive systems and egg development of Schistosoma japonicum," has been formally accepted for publication in PLOS Neglected Tropical Diseases.

We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases